|~100 grams per day (at 100 mg or 300 mg)1|
There have been no head-to-head clinical trials comparing the efficacy or safety of SGLT2 inhibitors. No direct evaluation of comparative clinical profiles can be made.
|Farxiga® (dapagliflozin)||Jardiance® (empagliflozin)|
|~70 grams per day (at 5 mg or 10 mg)3||
~64 grams per day (at 10 mg)4
Urinary glucose excretion rates shown are from the Prescribing Information for each marketed SGLT2 inhibitor.
Steglatro™ (ertugliflozin) at 5 mg and at 15 mg did not report urinary glucose excretion in its Prescribing Information.5
Indicated trademarks are registered trademarks of their respective owners.